GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » Accounts Payable & Accrued Expense

Liaoning Chengda Biotechnology Co (SHSE:688739) Accounts Payable & Accrued Expense : ¥385 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense?

Liaoning Chengda Biotechnology Co's quarterly accounts payable & accrued expense increased from Jun. 2024 (¥369 Mil) to Sep. 2024 (¥373 Mil) and increased from Sep. 2024 (¥373 Mil) to Dec. 2024 (¥385 Mil).

Liaoning Chengda Biotechnology Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥268 Mil) to Dec. 2023 (¥350 Mil) and increased from Dec. 2023 (¥350 Mil) to Dec. 2024 (¥385 Mil).


Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 224.21 281.42 268.29 349.95 384.52

Liaoning Chengda Biotechnology Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 349.95 318.11 369.01 373.38 384.52

Liaoning Chengda Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Liaoning Chengda Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines